Advanced in Obesity

Rodolphe Anty

Nice, FR 
Advanced in Obesity
Nice, FR 
OverviewLocationsClinical Research

Overview

Rodolphe Anty practices in Nice, France. Mr. Anty is rated as an Advanced expert by MediFind in the treatment of Obesity. His top areas of expertise are Spontaneous Bacterial Peritonitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 39 articles and participated in 1 clinical trial in the study of Obesity.

Gender
Male

Locations

Nice, France
Other Locations
Montpellier, France
Caen, France
France
Poitiers, France
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drug: Tislelizumab
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
Enrollment Status: Active_not_recruiting
Publish Date: April 10, 2024
Intervention Type: Diagnostic test
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Enrollment Status: Completed
Publish Date: March 26, 2021
Intervention Type: Other
Evaluation of the Efficacy of an Antibiotic Combined With Standard Treatment in Severe Alcoholic Hepatitis
Evaluation of the Efficacy of an Antibiotic Combined With Standard Treatment in Severe Alcoholic Hepatitis
Enrollment Status: Completed
Publish Date: March 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Study of cccDNA in Liver Transplant Patients With B Virus Markers
Study of cccDNA in Liver Transplant Patients With B Virus Markers
Enrollment Status: Completed
Publish Date: January 11, 2019
Intervention Type: Biological
View 8 Less Clinical Trials

124 Total Publications

Management of patients with type 2 diabetes and MASLD: an overview and joint statement.
Management of patients with type 2 diabetes and MASLD: an overview and joint statement.
Journal: Diabetes & metabolism
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Anty's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile